- Home
- TBPH vs HOUS Comparison
TBPH vs HOUS Comparison
Compare TBPH & HOUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TBPH
- HOUS
- Stock Information
- Founded
- TBPH 2013
- HOUS 2006
- Country
- TBPH United States
- HOUS United States
- Employees
- TBPH N/A
- HOUS N/A
- Industry
- TBPH Biotechnology: Pharmaceutical Preparations
- HOUS Real Estate
- Sector
- TBPH Health Care
- HOUS Finance
- Exchange
- TBPH Nasdaq
- HOUS Nasdaq
- Market Cap
- TBPH 699.0M
- HOUS 576.8M
- IPO Year
- TBPH N/A
- HOUS 2006
- Fundamental
- Price
- TBPH $13.95
- HOUS $6.46
- Analyst Decision
- TBPH Strong Buy
- HOUS Sell
- Analyst Count
- TBPH 3
- HOUS 2
- Target Price
- TBPH $21.33
- HOUS $4.00
- AVG Volume (30 Days)
- TBPH 602.7K
- HOUS 1.3M
- Earning Date
- TBPH 08-12-2025
- HOUS 11-06-2025
- Dividend Yield
- TBPH N/A
- HOUS N/A
- EPS Growth
- TBPH N/A
- HOUS N/A
- EPS
- TBPH 0.26
- HOUS N/A
- Revenue
- TBPH $77,205,000.00
- HOUS $5,783,000,000.00
- Revenue This Year
- TBPH $78.36
- HOUS $7.03
- Revenue Next Year
- TBPH N/A
- HOUS $6.25
- P/E Ratio
- TBPH $54.52
- HOUS N/A
- Revenue Growth
- TBPH 24.49
- HOUS 2.74
- 52 Week Low
- TBPH $7.88
- HOUS $2.71
- 52 Week High
- TBPH $14.55
- HOUS $6.63
- Technical
- Relative Strength Index (RSI)
- TBPH 71.41
- HOUS 67.52
- Support Level
- TBPH $13.66
- HOUS $5.82
- Resistance Level
- TBPH $14.55
- HOUS $6.63
- Average True Range (ATR)
- TBPH 0.46
- HOUS 0.31
- MACD
- TBPH -0.02
- HOUS -0.01
- Stochastic Oscillator
- TBPH 56.20
- HOUS 86.72
About TBPH Theravance Biopharma Inc.
Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).
About HOUS Anywhere Real Estate Inc.
Anywhere Real Estate Inc operates in residential real estate, focusing on brokerage, relocation, title, settlement businesses, and mortgage and title insurance ventures. It supports approximately 1 million home sale sides annually. Brands include Better Homes and Gardens, CENTURY 21, Coldwell Banker, Corcoran, ERA, and Sotheby's International Realty. Revenue comes mainly from existing home transactions. Operations are segmented into Anywhere Brands (franchises), Anywhere Advisors (owned brokerage), and Anywhere Integrated Services (title and settlement).